Healthcare - Biotechnology - NASDAQ - US
$ 9.68
-4.06 %
$ 2.89 B
Market Cap
-28.47
P/E
Price Target
Average
73.04%
Revenue Forecast
Estimate
31.03%
EBIT
Estimate
--83.28%
Net Income
Estimate
48.05%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Amicus Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for FOLD of $16.8 , with forecasts ranging from a low of $13 to a high of $20 .
FOLD Lowest Price Target
Wall Street Target
13 USD
34.30%
FOLD Average Price Target
Wall Street Target
16.8 USD
73.04%
FOLD Highest Price Target
Wall Street Target
20 USD
106.61%
REVENUE FORECAST
Revenue Forecast Chart FOLD
EBIT FORECAST
EBIT Forecast Chart FOLD
NET INCOME FORECAST
Net Income Chart FOLD